With a market capitalization (market cap) of $1.15B — a measure of how much the company is worth — Akso Health Group ranks #2,393 among the 2,502 companies tracked, and 327th in Healthcare as of October 17, 2026. Shares trade at $1.35, up 0.00% on the day.
of 2,502 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series — they can diverge when the share count changes. Those returns are not a CAGR until you pick a start value, an ending value, and years. CAGR calculator. Market cap vs. stock price.
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation October 16, 2026. Ranking headline cap is the snapshot figure as of October 17, 2026.
| Year | As of | Market cap | Annual change | Year-end close |
|---|---|---|---|---|
| 2026 | Oct 16, 2026 | $975.65M | +78.89% | $1.35 |
| 2025 | Dec 31, 2025 | $545.38M | +20.59% | $1.64 |
| 2024 | Dec 31, 2024 | $452.27M | +2,839.49% | $1.36 |
| 2023 | Dec 29, 2023 | $15.39M | +451.31% | $0.74 |
Ranking figure $1.15B as of October 17, 2026.
Akso Health Group's ranking market cap is the provider-reported capitalization on the same snapshot as the rest of this site, with a share price of $1.35 as of October 16, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $975.65M on October 16, 2026. See how the ranking works.
The ranking snapshot ($1.15B as of October 17, 2026) is FMP company-screener market cap. The historical observation ($975.65M on October 16, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap agrees with the ranking snapshot. This listing is an ADR. This site does not have an ADS ratio, so it does not rescale either figure. This page does not replace one series with the other.
Live shares outstanding are not on the quote used for price, so this page does not invent a current share count. Shares outstanding vs. float.
The latest annual report (FY 2026) used a weighted-average 722,707,254 shares. That figure is an average for the year, not the live count in the market-cap formula.
Multiplying the latest price by those FY 2026 weighted-average shares would give about $975.65M. The ranking uses the provider's reported market cap instead, which reflects a current share count rather than that annual average.
This listing is an ADR. The market cap here is for the U.S. listing we rank; we do not have an ADR ratio, so we do not scale this figure to the parent company's local share count.
Book equity: assets minus liabilities on the latest annual report.
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
Not in this snapshot
FY 2026 net worth
Largest U.S.-listed names in the same FMP sector — not a hand-picked competitor set.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #11 | Eli Lilly and Company LLY | $1.18T | +0.43% |
| #21 | Johnson & Johnson JNJ | $615.87B | +0.90% |
| #23 |
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes.
Summary from the company profile (Financial Modeling Prep). Principal financial figures above are for FY 2026.
Visit websiteAs of October 17, 2026, Akso Health Group (AHG) is worth $1.15B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. For FY 2026, Akso Health Group’s book equity is about $180.92M. Market cap is the market value of the outstanding shares. As of October 17, 2026, its market cap is $1.15B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
Akso Health Group ranks #2,393 among the 2,502 companies tracked on MarketCapLens. In Healthcare it ranks #327 of 353.
Fundamentals are annual. Figures labeled with their fiscal year. Live ratios use the current price against those annual earnings.
Over the past year, market cap and share price moved by different amounts. Share count can change independently of price. What changes market cap.
| 2022 |
|---|
| Dec 30, 2022 |
| $2.79M |
| -71.93% |
| $0.376 |
| 2021 | Dec 31, 2021 | $9.94M | — | $1.64 |
|---|
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
Not in this snapshot
FY 2026
| $504.37B |
| +0.71% |
| #32 | UnitedHealth Group Incorporated UNH | $360.32B | -1.29% |
| #33 | Merck & Co., Inc. MRK | $360.12B | +0.53% |
| #45 | Novartis AG NVS | $286.29B | +0.16% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #2390 | Ladder Capital Corp LADR | $1.16B | +3.29% |
| #2391 | Carter's Inc. CRI | $1.15B | -3.65% |
| #2392 | Vizsla Silver Corp. VZLA | $1.15B | -2.11% |
| #2394 | Seneca Foods Corporation SENEA | $1.15B | -3.27% |
| #2395 | Syndax Pharmaceuticals, Inc. SNDX | $1.15B | -5.49% |
| #2396 | Dauch Corp. DCH | $1.15B | -5.10% |
Akso Health Group’s ranking market cap of $1.15B comes from the same snapshot as the rest of this site, as of October 17, 2026. It is not share price multiplied by the FY 2026 weighted-average share count of 722,707,254. The ranking snapshot ($1.15B as of October 17, 2026) is FMP company-screener market cap. The historical observation ($975.65M on October 16, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap agrees with the ranking snapshot. This listing is an ADR. This site does not have an ADS ratio, so it does not rescale either figure. This page does not replace one series with the other.
Over the past year, Akso Health Group’s market cap is up 76.74%, using historical market-cap records rather than today’s share count applied to past prices.
Akso Health Group (AHG) shares trade at $1.35, up 0.00% on the day, as of October 17, 2026.
Live P/E is share price divided by annual earnings per share. It is blank when earnings are missing, zero, or negative — not a 0× multiple.